Who has invested in Tris Pharma?

Deerfield Management Company are named among the investors backing Tris Pharma.

Tris Pharma Funding: $125M Raised, Series B (2018)

Tris Pharma funding overview

Tris Pharma is based in Monmouth Junction. Tris Pharma has raised $125M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in October 2018. The round record for Tris Pharma runs through 2018; nothing later has been disclosed. Investors on record include Deerfield Management Company.

Tris Pharma at a glance

Total raised: $125M
Latest round: Series B
Latest round date: October 2018
Headquarters: Monmouth Junction
Notable investors: Deerfield Management Company

Frequently asked about Tris Pharma funding

How much has Tris Pharma raised?: Tris Pharma has raised $125M in total disclosed funding across the rounds on record.
Who has invested in Tris Pharma?: Deerfield Management Company are named among the investors backing Tris Pharma.
What was the latest Tris Pharma funding round?: The most recent disclosed round is a Series B, announced in October 2018.
Where is Tris Pharma based?: Tris Pharma is based in Monmouth Junction.
When did Tris Pharma last raise?: The last disclosed Tris Pharma round closed in October 2018 at Series B.

Round data for Tris Pharma is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Monmouth Junction and backer lists below.

Tris Pharma Funding: $125M Raised, Series B (2018)

Tris Pharma funding overview

Tris Pharma at a glance

Frequently asked about Tris Pharma funding

Companies related to Tris Pharma (13)

Browse related funding lists (4)